23antMe bankruptcy in 11 of the 11th as the resignation of bankrupt and CEO Wojcicki in Chapter 11

23AndMe resigns as a bankrupt defense and his co-founder and CEO resigned in Chapter 11 Genetic Test Company Continues their boosts to reduce costs.

The company said that this would look for “all assets” through the court approved by the court.

San Francisco-based company, Anne Wojcicki has resigned as CEO immediately entered into force, but he will stay on the company’s board. His resignation comes after a few weeks after the Board Committee’s Wojcicki never rejected the fact that he had never been checked.

Shares of 23Andme Holding Co., which has been worth their value since last spring, fell from $ 1 to the post on Monday.

Volunteer bankruptcy table, which has fought to find a profitable business model since 2021.

Last September, Its all independent directors resigned Move in a rare way after negotiations with Wojcicki trying to take the company private.

The company then announced that in November will take out 40% or more than 40% of the workforce and stop the therapeutic section.

In January, the Special Committee of the Board, said the strategic alternatives, including a possible sale, he said.

Chairman of the Board Mark Jensen, in a statement on Sunday, the company determined that a sale in court’s control was “the best way to increase the cost of work.” He said that this is waiting for the company to help reduce costs and solve the efforts to solve legal entities and lease.

Jensen said: “We continue to be transparent to protect customer information and manage user information and be transparent on an important consideration of information confidentiality.”

23Andome plans to continue his work and is $ 35 million in debt financing from the capital partners of JMB.